Download
s00392-021-01976-y.pdf 323,69KB
WeightNameValue
1000 Titel
  • Influence of body size on platelet response to ticagrelor and prasugrel in patients with acute coronary syndromes
1000 Autor/in
  1. Ndrepepa, Gjin |
  2. Holdenrieder, Stefan |
  3. Bernlochner, Isabell |
  4. Kastrati, Adnan |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-12-01
1000 Erschienen in
1000 Quellenangabe
  • 111(7):838-842
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00392-021-01976-y |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242954/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Rheumatic diseases frequently present with pulmonary involvement. All anatomic structures of the lungs can be affected. Interstitial lung diseases are characterized by a system of patterns evident in high-resolution computed tomography (HR-CT) scanning of the lungs. The HR-CT pattern can differ between rheumatic diseases.!##!Objective!#!Systematic description of all variants and patterns of pulmonary involvement in rheumatic diseases.!##!Material and methods!#!Narrative review based on the current literature on the topic from the perspective of rheumatology, pulmonary diseases and radiology.!##!Results!#!Pulmonary involvement is frequent and prognostically relevant. The summary of pulmonary involvement reveals a high variability of affected anatomical structures as well as patterns of interstitial diseases for inflammatory rheumatic diseases. A synopsis of the main diagnostic findings is provided.!##!Conclusion!#!Every rheumatic disease presented here can be associated with pulmonary involvement. Therefore, a systematic diagnostic evaluation is mandatory at the first diagnosis as well as during follow-up. Apart from clinical findings and lung function HR-CT of the lungs is decisive for the diagnostics.
1000 Sacherschließung
lokal Body Size [MeSH]
lokal Acute Coronary Syndrome/drug therapy [MeSH]
lokal Percutaneous Coronary Intervention [MeSH]
lokal Prasugrel Hydrochloride/therapeutic use [MeSH]
lokal Humans [MeSH]
lokal Letter to the Editors
lokal Platelet Aggregation Inhibitors/adverse effects [MeSH]
lokal Cardiology
lokal Treatment Outcome [MeSH]
lokal Ticagrelor/therapeutic use [MeSH]
lokal Purinergic P2Y Receptor Antagonists/adverse effects [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-8725-055X|https://frl.publisso.de/adhoc/uri/SG9sZGVucmllZGVyLCBTdGVmYW4=|https://frl.publisso.de/adhoc/uri/QmVybmxvY2huZXIsIElzYWJlbGw=|https://frl.publisso.de/adhoc/uri/S2FzdHJhdGksIEFkbmFu
1000 Hinweis
  • DeepGreen-ID: e425503b15b64c2c8ebc5e0074ff3123 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6450838.rdf
1000 Erstellt am 2023-05-11T11:13:18.782+0200
1000 Erstellt von 322
1000 beschreibt frl:6450838
1000 Zuletzt bearbeitet 2023-10-14T08:58:35.984+0200
1000 Objekt bearb. Sat Oct 14 08:58:35 CEST 2023
1000 Vgl. frl:6450838
1000 Oai Id
  1. oai:frl.publisso.de:frl:6450838 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source